Discovery and Development of Novel Antimalarials and Their Use as Chemical Tools to Discover New Biology of the Malaria Parasite—a Pharma/Academic Collaboration

Event Details

Type

Other Seminars

Speaker(s)

Alan Cowman, AC, FRS, FAA, professor, acting director, WEHI - Walter and Eliza Hall Institute of Medical Research

Speaker bio(s)

Alan F. Cowman AC FRS FAA is Acting Director at the Walter and Eliza Hall Institute of Medical Research (WEHI) in Melbourne, Australia. He did his undergraduate degrees at Griffith University in Brisbane, Australia followed by a PhD at WEHI. After a two-year postdoctoral fellowship at University of California – Berkeley with Gerry Rubin working on Drosophila he returned to WEHI and developed a laboratory studying malaria. He has worked on malaria for over 30 years and published over 360 papers on infection and pathogenesis to understand the function of proteins in Plasmodium falciparum, the causative agent of the most severe form of malaria. He was elected as a Fellow to the Royal Society in 2011. The aim of his laboratory is to understand the function of proteins involved in the development of the malaria parasite. His laboratory collaborates with Merck USA to discover and develop novel antimalarials and a clinical candidate is currently in first in human clinical trials.

Open to

Tri-Institutional